drugset / Trial / NCT02365558
A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the effect of increased stomach pH on how much evacetrapib is found in the blood stream and how long the body takes to get rid of it when given to healthy participants. Information about any side effects that may occur will also be collected. There are two parts to the study. Participation in both parts will be required. The study will last approximately 30 days, not including screening.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-04
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Evacetrapib | Small molecule | — | Oral |
| Background | Omeprazole | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.